Zobrazeno 1 - 10
of 776
pro vyhledávání: '"L Van der Poel"'
Autor:
de Groot, Roelof (Roel)
Publikováno v:
Tijdschrift voor Orthopedagogiek, 3, 121-122
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::be369b3080afc0e80e11579fa141853d
https://research.rug.nl/en/publications/89e52e0a-3348-4c91-814b-24116ea1bbd7
https://research.rug.nl/en/publications/89e52e0a-3348-4c91-814b-24116ea1bbd7
Publikováno v:
Tijdschrift voor Orthopedagogiek. 3:121-122
Autor:
Church, Alonzo
Publikováno v:
The Journal of Symbolic Logic, 1959 Mar 01. 24(1), 78-78.
Externí odkaz:
https://www.jstor.org/stable/2964626
Autor:
K. Honney, M Kaneshamoorthy, Sarah Hopkins, H Mark, A Balogun, P Athauda, A Halliday, M Vincent, L Van der Poel, Z Fritz, A Jakupaj, D Ondhia, Stephen Barclay, C Pampali
Publikováno v:
Age and Ageing. 49:i30-i32
Introduction When a doctor is informed of a patient’s future care preferences if they were to lose capacity, there is an ethical and legal obligation to share this information with the treating medical team. In frail older patients, conversations a
Autor:
S. H. Valentine
Publikováno v:
Software: Practice and Experience. 7:150-151
Autor:
Alonzo Church
Publikováno v:
Journal of Symbolic Logic. 24:78-78
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mart P. Janssen, Cees L. van der Poel, Hans L. Zaaijer, Welling Oei, Mirjam Kretzschmar, Roel A. Coutinho
Publikováno v:
Transfusion. 54:1705-1711
Background The Q fever outbreaks in the Netherlands in 2007 to 2009 initiated discussion on the necessity of measures to prevent transmission through blood products. Risk assessments help transfusion regulators decide when and where measures are requ
Autor:
Jim E. van Steenbergen, Welling Oei, Sybille Rehmet, Mirjam Kretzschmar, Mart P. Janssen, Cees L. van der Poel
Publikováno v:
Transfusion. 53:1421-1428
BACKGROUND: A timely risk assessment is desired to guide decisions on preventive transfusion safety measures during emerging infectious disease (EID) outbreaks. The European Up-Front Risk Assessment Tool (EUFRAT) model was developed to provide quanti